Advertisement

Topics

Iroko Pharmaceuticals, LLC Company Profile

08:25 EDT 30th May 2016 | BioPortfolio

Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global basis through focused selling and marketing efforts and product-life-cycle management activities including development of new formulations to improve patient treatment.


News Articles [801 Associated News Articles listed on BioPortfolio]

Survey: Patients with pain cannot identify NSAIDs, do not discuss pain with their physicians

Although an Iroko Pharmaceuticals-funded survey of 1,056 American adults showed 77% of those surveyed experienced at least some type of pain and 43% experienced pain weekly, half of respondents were u...

Vivlodex now available in United States for osteoarthritis pain

Iroko Pharmaceuticals LLC announced its proprietary, low-dose form of meloxicam, Vivlodex, is now available in pharmacies in the United States, according to a company press release. In a 12-week study...

Iroko announces Vivlodex availability

The low-dose NSAID was approved by the Food and Drug Administration in October to treat osteoarthritis pain.  read more

Iroko Pharmaceuticals to Present Phase 3 VIVLODEX® Efficacy and Safety Data at World Congress of Osteoarthritis

PHILADELPHIA, March 31, 2016 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that it will pr...

ORIC Pharmaceuticals raises $53M for drugs that attack treatment-resistant cancers

ORIC Pharmaceuticals is being led by Richard Heyman, the serial biopharma entrepreneur behind companies like Aragon Pharmaceuticals, Seragon Pharmaceuticals and Metacrine.

VIVLODEX™ Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain

PHILADELPHIA, Feb. 16, 2016 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that VIVLODEX™ ...

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11....

Bafna Pharmaceuticals Limited (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Bafna Pharmaceuticals Limited (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. Thi...

Drugs and Medications [0 Results]

None

PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

Removal of pharmaceuticals from secondary effluents by an electro-peroxone process.

This study compared the removal of pharmaceuticals from secondary effluents of wastewater treatment plants (WWTPs) by conventional ozonation and the electro-peroxone (E-peroxone) process, which involv...

Ranking Prescribed Pharmaceuticals in Terms of Environmental Risk: Inclusion of Hospital Data and the Importance of Regular Review.

A newly available dataset on pharmaceuticals used in Scottish hospitals enabled an Environmental Risk Assessment that includes hospital consumption of pharmaceuticals, as previous UK rankings have bee...

Uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin and propranolol, in Daphnia magna.

The objective of the present study was to investigate the uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin (ROX) and propranolol (PRP), in Daphnia magna via aqueous expos...

Acute toxicities of pharmaceuticals toward green algae. mode of action, biopharmaceutical drug disposition classification system and quantile regression models.

The acute toxicities of 36 pharmaceuticals towards green algae were estimated from a set of quantile regression models representing the first global quantitative structure-activity relationships. The ...

Assessing environmental risk of pharmaceuticals in Portugal: An approach for the selection of the Portuguese monitoring stations in line with Directive 2013/39/EU.

In line with the Directive 2013/39/EU the most representative surface waters, regarding pharmaceuticals contamination, were selected based on a Portuguese nationwide monitoring exercise. To meet this ...

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Iroko Pharmaceuticals, LLC

Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global bas...

Iroko Pharmaceuticals, LLC and SynopiaRx LLC

Iroko is a pharmaceutical company focused on the development and commercialization of innovative specialty therapeutic products. The company acquires, develops and maximizes the p...

Iroko Cardio International Sàrl

IROKO Cardio has been founded to organize and support the commercial effort for Aggrastat. In close cooperation with our worldwide distribution partners, we aim to provide state o...

Iroko Pharmaceuticals Inc.

Iroko Pharmaceuticals, LLC and Aptuit Inc.

More Information about "Iroko Pharmaceuticals, LLC" on BioPortfolio

We have published hundreds of Iroko Pharmaceuticals, LLC news stories on BioPortfolio along with dozens of Iroko Pharmaceuticals, LLC Clinical Trials and PubMed Articles about Iroko Pharmaceuticals, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Iroko Pharmaceuticals, LLC Companies in our database. You can also find out about relevant Iroko Pharmaceuticals, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record